J9041

Code

J9041

Description

Injection, bortezomib, 0.1 mg

CMS HCPCS quarterly update

• 00143-9098-01 Bortezomib, Hikma Pharmaceuticals USA Inc.. Billable units per 11-digit NDC: 35.
• 00409-1700-01 Bortezomib, Pfizer Inc. Billable units per 11-digit NDC: 35.
• 10019-0991-01 Bortezomib, Baxter Healthcare Corporation. Billable units per 11-digit NDC: 35.
• 25021-0244-10 Bortezomib, Sagent Pharmaceuticals. Billable units per 11-digit NDC: 35.
• 25021-0262-10 Bortezomib, Sagent Pharmaceuticals. Billable units per 11-digit NDC: 35.
• 43598-0426-60 Bortezomib, Dr. Reddy's Laboratories Inc.. Billable units per 11-digit NDC: 35.
• 50742-0484-01 Bortezomib, Ingenus Pharmaceuticals LLC. Billable units per 11-digit NDC: 35.
• 55150-0337-01 Bortezomib, Eugia US LLC. Billable units per 11-digit NDC: 35.
• 60505-6050-04 Bortezomib, Apotex Corp. Billable units per 11-digit NDC: 35.
• 63020-0049-01 Velcade, Takeda Pharmaceuticals America, Inc.. Billable units per 11-digit NDC: 35.
• 63323-0821-10 Bortezomib, FreseniUS Kabi USA, LLC. Billable units per 11-digit NDC: 35.
• 68001-0534-36 Bortezomib, BluePoint Laboratories. Billable units per 11-digit NDC: 35.
• 68001-0540-36 Bortezomib, BluePoint Laboratories. Billable units per 11-digit NDC: 35.
• 68001-0541-36 Bortezomib, BluePoint Laboratories. Billable units per 11-digit NDC: 35.
• 70069-0836-01 Bortezomib, Somerset Pharma, LLC. Billable units per 11-digit NDC: 35.
• 70710-1411-01 Bortezomib, Zydus Pharmaceuticals (USA) Inc.. Billable units per 11-digit NDC: 35.
• 70860-0225-10 Bortezomib, Athenex Pharmaceutical Division, LLC. Billable units per 11-digit NDC: 35.
• 71288-0118-10 Bortezomib, Meitheal Pharmaceuticals Inc.. Billable units per 11-digit NDC: 35.
• 72205-0183-01 Bortezomib, Novadoz Pharmaceuticals LLC. Billable units per 11-digit NDC: 35.
• 72603-0270-01 Bortezomib, Northstar RxLLC. Billable units per 11-digit NDC: 35.

Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.